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Abstract L-cysteine is an essential amino acid that helps in improving the overall health status of humans. The objective of the study was to determine the impact on the physicochemical and thermal properties of L-cysteine after the Trivedi Effect®-Consciousness Energy Healing Treatment using 
modern analytical techniques. The control sample was kept without any treatment, while the Biofield Treatment was given to the treated sample 
remotely by a renowned Biofield Energy Healer, Gopal Nayak. The particle size values were significantly reduced by 11.96%(d10), 9.01%(d50), 
4.92%(d90), and 7.66% [D (4, 3)], thus, the specific surface area was significantly increased by 14.28% of the treated L-cysteine compared to the 
control sample. The peak intensities and crystallite sizes were altered ranging from -86.73% to 456.65% and -4.91% to 451.22% respectively, 
however, the average crystallite size was significantly increased by 87.58% in the treated sample compared to the control sample. The latent heat of decomposition for the 1st and 2nd peak of the treated sample was increased by 12.77% and 5.42% respectively, compared with the control 
sample. The weight loss was increased by 9.35%; however, the residual weight was significantly reduced by 85.32% in the treated sample 
compared to the control sample. The maximum thermal degradation temperature of the treated sample was increased by 2.87% compared to 
the control sample. Hence, the Biofield Energy Treated L-cysteine might show better solubility, dissolution, bioavailability, and be more thermal 
stability in the pharmaceutical formulations, which would be more efficacious in the treatment of diabetes, cancer, psychosis, and seizures compared to the control sample.
Keyword: L-cysteine; The Trivedi Effect®; Energy of consciousness healing treatment; Complementary and alternative medicine; PSA; PXRD; 
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IntroductionCysteine is an essential amino acid that contains sulphur, which allows it to get bonded and maintain its structure 
within the body [1]. Cysteine is considered an essential as it is 
the basic building block of the glutathione formation (mother antioxidant) and used by the body to produce taurine, i.e., 
also an amino acid [2]. L-cysteine had several other uses that help in improving the overall health status of humans. One 
of its supplements, N-acetyl-L-cysteine (NAC), is used for improving the level of glutathione within the body, as the right glutathione level supports the functioning of brain, lungs, and 
immunity, and helps in liver detoxification [3]. L-cysteine also 
acts as a scavenger that fights with the free radicals of the body. Such radicals cause cellular damage in the body by the process of oxidative stress; therefore, L-cysteine preserves the glutathione in the body and improves the antioxidant capacity 
[4,5]. The supplements containing L-cysteine are also used to improve the immunity in postmenopausal women; prevent the side effects from toxic chemicals and drug reactions; treat 
 infertility in men having the poor quality of semen; improve 
the digestive capacity; slow the aging process [6-9]. Other functions of L-cysteine in the body includes balancing the blood sugar levels, relieving the symptoms of bronchitis or chronic 
obstructive pulmonary disease (COPD), and treating some 
psychiatric disorders [10-12]. The physicochemical properties of amino acids, such as L-cysteine, play important role in its biological performance within the body. Thus, efforts were made by several researchers to improve such physicochemical 
profile of the compound that ultimately affects their biological activities, such as improving the solubility and absorption 
by reducing the particle size, increasing the surface area, or 
modifying the crystal morphology [13,14]. In this scenario, the 
Biofield Energy Treatment is known for its significant impact 
on various properties of living and non-living objects [15,16].
The Biofield energy is a unique phenomenon that involves the traditional as well as the contemporary models of energy medicine and is used as the Complementary and Alternative 
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Medicine (CAM) to fight against various diseases and disorders 
[17-19]. The Biofield Energy Healing is an Energy therapy that is used in wide population of the USA and also accepted by the National Centre for Complementary and Alternative 
Medicine (NCCAM) along with Ayurvedic medicine, traditional Chinese herbs and medicines, naturopathy, essential oils, homeopathy, yoga, meditation, massage, acupuncture, acupressure, Tai Chi, Qi Gong, deep breathing, special diets, relaxation techniques, aromatherapy, guided imagery, healing touch, Reiki, chiropractic/osteopathic manipulation, 
movement therapy, hypnotherapy, pilates, Rolfing structural integration, mindfulness, cranial sacral therapy, and applied 
prayer [20]. Thus, an expert human can harness energy from 
the universal and can transmit it to any living organism(s) or 
non-living object(s) around the globe. Similarly, the Trivedi Effect®-Consciousness Energy Healing Treatment has shown 
remarkable impacts in the field of agriculture science [21,22], 
microbiology [23-25], metals and ceramics [26,27], livestock 
[28], biotechnology [29,30], and human health and wellness [31-
33]. Moreover, the impact of The Biofield Energy Treatment is also evident on the physicochemical and thermal properties of 
various organic and pharmaceutical compounds [34-36]. Thus, this study was done with the objective to determine the effect of 
the Biofield Energy Healing Treatment (the Trivedi Effect®) on the physicochemical and thermal properties of L-cysteine with 
the help of several analytical techniques such as particle size 
analysis (PSA), powder X-ray diffraction (PXRD), differential 
scanning calorimetry (DSC), and thermogravimetric analysis 
(TGA)/differential thermogravimetric analysis (DTG).Thus, this study was also aimed to analyse the impact 
of the Biofield Energy Healing Treatment (The Trivedi Effect®) on the physicochemical and thermal properties of ascorbic acid by using various analytical techniques such 
as, particle size analysis (PSA), powder X-ray diffraction 
(PXRD), thermogravimetric analysis (TGA)/ differential 
thermogravimetric analysis (DTG), and differential scanning 
calorimetry (DSC).
Materials and Methods 
Chemicals and reagentsL-cysteine was purchased from Alfa Aesar, USA. All other chemicals used during the experiments were of analytical grade available in India. 
Consciousness energy healing treatment strategiesIn this study, the test compound used was L-cysteine, which was divided into two parts, i.e., control and treated. The 
control sample was not given the Biofield Energy Treatment; however, the treated part of L-cysteine received the Energy of 
Consciousness Healing Treatment by the renowned Biofield 
Energy Healer, Gopal Nayak (India), and considered as the 
Biofield Energy Treated sample. The process of Biofield Energy Treatment involves keeping the sample under the standard 
laboratory conditions and then the Biofield Energy Healer 
provided the Trivedi Effect®-Energy of Consciousness Healing Treatment to the sample, remotely, for 3 minutes through the Unique Energy Transmission process. The control L-cysteine was further subjected to a “sham” healer under the similar laboratory conditions, who did not have any knowledge about 
the Biofield Energy Healing Treatment. The control and the 
Biofield Energy Treated L-cysteine samples were kept in 
similar sealed conditions and further characterized by using 
PSA, PXRD, DSC, and TGA/DTG techniques.
Characterization
Particle size analysis (PSA): The particle size analysis of 
the L-cysteine was conducted on Malvern Mastersizer 2000, from the UK with a detection range between 0.01 µm to 3000 
µm using wet method [37,38]. The sample unit (Hydro MV) 
was filled with a dispersant medium (sunflower oil), and the stirrer operated at 2500rpm. PSA of L-cysteine was performed 
to obtain the average particle size distribution. Where d 
(0.1) μm, d (0.5) μm, d (0.9) μm represent particle diameter 
corresponding to 10%, 50%, and 90% of the cumulative 
distribution. D (4,3) represents the average mass-volume 
diameter, and SSA is the specific surface area (m2/g). The 
calculations were done by using software Mastersizer Ver. 5.54.
The percent change in particle size (d) for at below 10% 
level (d10), 50% level (d50), 90% level (d90), and D (4,3) was calculated using the following equation 1:             (1)
Where dcontrol and dTreated  are the particle sizes (μm) at 
below 10% level (d10), 50% level (d50), and 90% level (d90) of the 
control and the Biofield Energy Treated samples, respectively. 
The percent change in surface area (S) was calculated using the following equation 2:
  (2)
Where Scontrol and STreated are the surface area of the control 
and the Biofield Energy Treated L-cysteine, respectively.
Powder X-ray Diffraction (PXRD) Analysis: The 
PXRD analysis of L-cysteine was performed with the help 
of RigakuMiniFlex-II Desktop X-ray diffractometer (Japan) 
[39,40]. The Cu Kα radiation source tube output voltage used 
was 30 kV and tube output current was 15 mA. Scans were 
performed at room temperature. The average size of individual 
crystallites was calculated from XRD data using the Scherrer’s 
formula (3):                                        
cos
kG λ
β θ
=                                         (3)
Where k is the equipment constant (0.94), G is the 
crystallite size in nm, λ  is the radiation wavelength (0.154056 
nm for Kα1 emission), β  is the full-width at half maximum 
(FWHM), and    θ is the Bragg angle [41]. The percent change 
in crystallite size (G) of L-cysteine was calculated using the following equation 4:
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        (4)
Where Gcontrol and GTreated are the crystallite size of the 
control and the Biofield Energy Treated samples, respectively.
Differential Scanning Calorimetry (DSC): The DSC 
analysis of L-cysteine was performed with the help of DSC Q200, TA instruments. Sample of  1-5 mg was loaded to the aluminium sample pan at a heating rate of 10oC/min from 
30°C to 350°C [37, 38]. The % change in melting point (T) was calculated using the following equation 5:                 (5)
Where Tcontrol and TTreated are the melting point of the control and treated samples, respectively.
The percent change in the latent heat of fusion ( ∆H) was calculated using the following equation 6:
   (6)
Where ∆Hcontrol and ∆HTreated are the latent heat of fusion of the control and treated L-cysteine, respectively.
Thermal Gravimetric Analysis (TGA)/ Differential 
Thermogravimetric Analysis (DTG): TGA/DTG thermograms of L-cysteine were obtained with the help of TGA Q50 TA 
instruments. A sample of 5 mg was loaded to the platinum crucible at a heating rate of 10°C/min from 25°C to 1000°C 
with the recent literature [37, 38]. The % change in weight loss 
(W) was calculated using the following equation 7:
    (7)
Where Wcontrol and WTreated are the weight loss of the control 
and the Biofield Energy Treated L-cysteine, respectively. The 
% change in maximum thermal degradation temperature ( Tmax 
) (M) was calculated using the following equation 8:               (8)
Where Mcontrol and MTreated  are the Tmax values of the control 
and the Biofield Energy Treated L-cysteine, respectively.
Results and Discussion
Particle size analysis (PSA)
The particle size analysis of the control and the Biofield Energy Treated L-cysteine samples corresponding to d10, d50, d90, and D (4, 3) was done (Table 1) to determine the impact of 
the Biofield Energy Treatment on the particle size distribution 
of L-cysteine. It revealed that the particle size distribution of 
the Biofield Energy Treated sample at d10, d50, d90, and D (4, 3) 
was significantly reduced by 11.96%, 9.01%, 4.92%, and 7.66%, respectively compared to the control sample. 
Table 1: Particle size distribution of the control and the Biofield Energy Treated L-cysteine.
Parameter d10 (µm) d50 (µm) d90 (µm) D (4,3) (µm) SSA(m2/g)Control 263.64 465.93 806.63 504.52 0.014
Biofield Treated 232.1 423.97 766.95 465.87 0.016
Percent change* (%) -11.96 -9.01 -4.92 -7.66 14.28d10, d50, and d90: particle diameter corresponding to 10%, 50%, and 90% of the cumulative distribution, D (4,3): the average mass-volume 
diameter, and SSA: the specific surface area. *denotes the percentage change in the Particle size distribution of the Biofield Energy Treated sample with respect to the control sample.
Such reduction in the particle sizes of the Biofield Energy 
Treated sample after the Biofield Energy Treatment resulted 
in 14.28% increase in the specific surface area of the Biofield 
Energy Treated sample (0.016 m2/g), in comparison to the 
untreated L-cysteine sample (0.014 m2/g). Several types of research were conducted nowadays that correlate the particle 
size and surface area of the compound with its solubility and 
dissolution profile [42,43]. Moreover, the reduced particle 
size and increased surface area of the compound are known for improving the solubility, absorption, and bioavailability 
performance in the body [44]. Thus, it is assumed that the 
Biofield Energy Treated L-cysteine might show better solubility and dissolution rate within the body that ultimately enhances its bioavailability in comparison to the untreated sample.
Powder X-ray diffraction (PXRD) analysis Figure 1 shows the diffractograms of the control and 
the Biofield Energy Treated L-cysteine samples; and both contains sharp and intense peaks, thereby indicating their crystalline nature. The analysis regarding the changes in the 
peak intensities and the crystallite sizes of the Biofield Energy Treated sample in comparison to the control sample was done and presented in Table 2. The analysis of the diffractograms 
revealed alterations in the Bragg’s angle of the characteristic 
peaks of the Biofield Energy Treated sample as compared to 
the control sample. Also, the highest peak intensity (100%) was observed at 2  equal to 37.13° in the control sample; 
while in the Biofield Energy Treated sample at 2  equal to 
24.91°. The significant alterations were observed in the peak 
intensities and the crystallite sizes of the Biofield Energy Treated L-cysteine sample as compared to the control sample. 
The Biofield Energy Treated sample showed changes in the 
peak intensities ranging from -86.73% to 456.65%; while the 
crystallite sizes were altered ranging from -74.91% to 451.22%, compared to the control sample. Such changes corresponding 
to the characteristic diffraction peaks of the Biofield Energy Treated sample showed that the crystallinity and crystalline structure of L-cysteine sample might get altered after the 
Biofield Energy Treatment as compared to the untreated sample.
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Table 2: PXRD data for the control and the Biofield Energy Treated L-cysteine.
Entry No.
Bragg angle (°2θ) Intensity (cps) Crystallite size (G, nm)
Control Treated Control Treated % change a Control Treated % change b1 13.35 13.27 55 7.3 -86.73 943 5198 451.222 18.64 18.34 71 198 178.87 857 711 -17.043 23.46 23.48 20.3 113 456.65 626 532 -15.024 24.91 24.79 176 664 277.27 352 764 117.055 28.48 28.54 12.9 20.4 58.14 590 1467 148.646 31.58 31.6 106 51.6 -51.32 817 205 -74.917 34.36 34.23 31 44 41.94 627 734 17.078 37.22 36.85 41 63 53.66 506 927 83.29 38.74 37.13 185 448 142.16 690 732 6.09adenotes the percentage change in the peak intensity of the Biofield Energy Treated sample with respect to the control sample; bdenotes the 
percentage change in the crystallite size of the Biofield Energy Treated sample with respect to the control sample.
Figure 1: PXRD diffractograms of the control and the Biofield 
Energy Treated L-cysteine.
The average crystallite size of the Biofield Energy Treated 
sample was 1252.22 nm, which was increased by 87.58% 
compared to the control sample (667.56 nm). The significant alterations in the crystal morphology and the crystallinity 
of the compounds after the Biofield Energy Treatment were reported previously in various studies. They reported the occurrence of such changes based on the alterations in their 
peak intensities and crystallite sizes of the Biofield Energy Treated compounds that might indicate the formation of a 
novel polymorph of the compound [45,46]. Thus, the Biofield 
Energy Treated L-cysteine showed significant changes in the 
peak intensities and crystallite size corresponding to the characteristic peaks that might take place as a result of the new 
polymorph formation of L-cysteine. The literature reported 
the improved bioavailability profile of drug as a result of the 
physical modifications, i.e., alteration in the crystal habit of the 
drug [47]. Hence, the Biofield Energy Treated L-cysteine might show improved bioavailability as compared to the untreated sample.
Differential scanning calorimetry (DSC) analysis 
Figure 2: DSC thermograms of the control and the Biofield 
Energy Treated L-cysteine.
The DSC thermograms of the control and the Biofield Energy Treated sample are shown in Figure 2, that are further analysed to determine the melting and other thermal behaviours of 
both the sample [48]. The literature reported that L-cysteine got decomposed instead of sublimation during its thermal 
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heating. It was mentioned that the peak in DSC thermogram was present at the same temperature as the drop in the TGA 
thermogram. Thus, the DSC peak temperature coincides with the TGA drop thereby, indicated the process of decomposition 
in place of melting during the heating of L-cysteine [48,49]. There were two peaks present in the thermograms of the 
control and the Biofield Energy Treated sample. The results 
revealed the alterations in the decomposition temperature of the 1st and 2nd peak of the Biofield Energy Treated sample 
by -2.51% and 0.46%, respectively in compared to the control 
sample. The latent heat of decomposition ( decompositionH∆  ) for 1st and 2nd peak of the Biofield Energy Treated L-cysteine sample 
was significantly increased by 12.77% and 5.42%, respectively, 
compared to the control sample (Table 3).
Table 3: Comparison of DSC data between the control and the Biofield Energy Treated L-cysteine.
Peak Description Melting Point (°C) ΔHdecomposition (J/g)
Peak 1 Control sample 182.88 21.38Biofield Treated sample 178.28 24.11
% Change* -2.51 12.77
Peak 2 Control sample 222.33 597.9Biofield Treated sample 223.35 630.3
% Change* 0.46 5.42
ΔH: Latent heat of decomposition; *denotes the percentage change of the Biofield Energy Treated sample with respect to the control sample.
The results indicated that the Biofield Energy Treated sample started decomposing  4.6º earlier temperature as compared to the control sample, which might be due to some 
changes in the particle size and crystallization structure of 
the L-cysteine [48,50] after the Biofield Energy Treatment. 
Thus, the Biofield Energy Treated sample showed an increase in thermal degradation in comparison to the untreated L-cysteine sample.
Thermal gravimetric analysis (TGA)/ Differential 
thermogravimetric analysis (DTG) The weight loss of the L-cysteine samples during the thermal degradation was analysed from the TGA thermograms 
(Figure 3) of the control and the Biofield Energy Treated 
sample. Also, the degradation profile of both the samples 
were observed like the reported literature [49]. The analysis of both the thermograms showed that the total weight loss 
of the control sample was 90.12%; whereas it was observed 
as 98.55% for the Biofield Energy Treated L-cysteine sample. Thus, the total weight loss during the thermal degradation of 
the Biofield Energy Treated sample was increased significantly 
by 9.35% that resulted in 85.32% decrease in the residual 
mass compared with the control sample (Table 4). Hence, the 
thermal degradation of the Biofield Energy Treated sample was 
increased after the Biofield Energy Treatment in comparison to the untreated sample. Figure 3: TGA thermograms of the control and the Biofield Energy Treated L-cysteine.
Table 4: TGA/DTG data of the control and the Biofield Energy Treated samples of L-cysteine.
Sample
TGA DTG
Total weight loss (%) Residue % Tmax (°C)Control 90.12 9.88 219.42
Biofield Energy Treated 98.55 1.45 225.72
% Change* 9.35 -85.32 2.87
*denotes the percentage change of the Biofield Energy Treated sample with respect to the control sample,Tmax = the temperature at which maximum weight loss takes place in TG or peak temperature in DTG.
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The DTG data (Table 4) (Figure 4) of the Biofield Energy Treated sample showed the maximum thermal degradation 
temperature ( Tmax ) at 225.72 °C, which was improved by  ∼ 
6 °C (2.87%) as compared to the Tmax of the control sample 
(219.42 °C). Hence, the overall TGA/DTG studies revealed that 
the thermal stability profile of the Biofield Energy Treated 
L-cysteine sample was altered after the Biofield Energy Treatment as compared with the untreated sample.
Figure 4: DTG thermograms of the control and the Biofield 
Energy Treated L-cysteine.
Conclusion
The study results suggested that there was a significant impact of the Trivedi Effect®-Consciousness Energy Healing 
Treatment on various properties of the Biofield Energy Treated L-cysteine sample related to their physicochemical 
and thermal profile. The PSD data showed that the particle size 
values of the Biofield Energy Treated sample were significantly reduced at d10, d50, d90, and D (4, 3) by 11.96%, 9.01%, 4.92%, and 
7.66%, respectively, compared to the untreated sample. The 
specific surface area of the Biofield Energy Treated L-cysteine 
was significantly increased by 14.28% in comparison to the 
untreated L-cysteine. The PXRD peak intensities of the Biofield Energy Treated L-cysteine were observed to be changed 
ranging from -86.73% to 456.65% and crystallite sizes showed 
alterations ranging from -74.91% to 451.22% as compared 
to the control sample. The average crystallite size of the 
Biofield Energy Treated sample was significantly increased 
by 87.58%, as compared to the control L-cysteine sample. 
The DSC thermograms of the control and the Biofield Energy Treated sample showed two peaks in their thermograms that 
are related to the decomposition of L-cysteine sample during heating. However, the   corresponding to 1st and 2nd peak 
were also observed to be significantly increased by 12.77% 
and 5.42%, respectively, compared to the control L-cysteine 
sample. The TGA/DTG data indicating that the Biofield Energy 
Treated sample showed 9.35% increase in total weight loss 
of the L-cysteine sample that causes a significant 85.32% reduction in the residue amount compared to the untreated 
sample. However, the   of the Biofield Energy Treated sample 
was increased by 2.87% compared to the control sample. 
Thus, the overall data showed the reduced particle sizes and 
increased surface area of the Biofield Energy Treated sample with alterations in the crystal structure, which might increase the solubility, absorption, and bioavailability of L-cysteine 
within the body. Also, the results indicating significant changes 
in the thermal degradation and stability profile of the Biofield Energy Treated L-cysteine sample compared to the untreated sample. Therefore, the Trivedi Effect®-Consciousness Energy Healing Treated L-cysteine might improve the properties that might ensure its better performance and therapeutic response against various diseases, i.e., diabetes, cancer, psychosis, and 
seizures.
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